Skip to main content

ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC) Investor Investigation Over Potential Breaches Of Fiduciary Duties Announced

  • If you are a current long-term stockholder of shares of ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

August 27, 2013 (Shareholders Foundation) - An investigation on behalf of current long-term stockholders of shares of ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC) was announced concerning whether certain ImmunoCellular Therapeutics officers and directors possibly breached their fiduciary duties in connection with certain statements. The investigation by a law firm concerns whether c...



You must register (for free) or login to view the entire investigation.